DoseDr
The business, the turning points, and the decisions behind them.
01 / WHAT IT BUILT
What the company did
DoseDr was a diabetes management startup that launched out of Y Combinator's Winter 2016 class. Its mobile app let patients track glucose readings and insulin injections and suggested exact insulin dose adjustments in real time between doctor visits, while providers could intervene remotely through a web portal. A pilot with five clinics and 50 high-risk patients brought 93 percent of participants into the safe range within the first month.
02 / DoseDr FAILURE REASONS
Failure reasons
DoseDr is listed as out of business as of December 2019. No public statement of specific failure reasons was found. The company had promising early clinical signals but never scaled: it remained a small team of about three people and did not disclose any follow-on funding or commercial traction after its 2016 seed round.
03 / EVENT HISTORY
Events in the structured record
- Founded and launched
DoseDr launched out of Y Combinator's Winter 2016 class with a mobile app for real-time insulin dose management; it ran a pilot with five clinics and 50 high-risk patients.
- Seed funding
The company raised a seed round with participation from Y Combinator, IT-Farm, Michael Seibel, Anthony Saleh, Emmett Shear, Kyle Vogt, and Nasir Jones, among others.
- Out of business
DoseDr is recorded as out of business as of December 2019.
04 / CONTEMPORARY REBUILD ASSESSMENT
Difficulty of rebuilding this project today
Material for this section is being gathered and checked. It will appear here once ready.
Overall assessment: Not completed
05 / CAUSAL CHAIN
How the factors connect
- 01
The company is recorded as out of business as of December 2019.
- 02
No public disclosure of remaining assets, liabilities, or investor recoveries was found.